As reductive carboxylation plays a crucial role in conferring bioenergetics and biosynthetic advantages for tumorigenesis in cells with defective mitochondria [35], it is possible that FH-deficient cells with lower levels of fumarate are selected during tumour progression to sustain survival and tumour growth. This evidence concerns the gene FH and neoplasm.